Vertex Pharmaceuticals Inc (VRTX) - Financial and Strategic SWOT Analysis Review

March 2021 | 60 pages | ID: V6A67E08D94EN
GlobalData

Abstracts

Vertex Pharmaceuticals Inc (VRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that discovers, develops and commercializes transformative drugs for the treatment of serious and life-threatening diseases. The company product portfolio includes Trikafta, Symdeko/Symkevi, Orkambi (ivacaftor/lumacaftor) and Kalydeco (ivacaftor) for the treatment of cystic fibrosis. Through its research and development efforts, the company focuses on influenza, cancer, neurological diseases and pain. Vertex has R&D centers and commercial offices in North America, South America, Europe and Australia. The company offers its products in the US, Europe, Australia and Canada. Vertex is headquartered in Boston, Massachusetts, the US.

Vertex Pharmaceuticals Inc Key Recent Developments

Feb 24,2021: Vertex to Present at the Cowen Health Care Conference on March 2
Feb 01,2021: Vertex Reports Full-Year and Fourth-Quarter 2020 Financial Results
Oct 29,2020: Vertex reports third-quarter 2020 financial results
Sep 17,2020: Moderna, Vertex partner on gene-editing therapies for cystic fibrosis
Sep 10,2020: The Vertex Foundation announces €1 million donation to Ronald McDonald House Charities at the new children’s hospital in Ireland

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Vertex Pharmaceuticals Inc - Key Facts
Vertex Pharmaceuticals Inc - Key Employees
Vertex Pharmaceuticals Inc - Key Employee Biographies
Vertex Pharmaceuticals Inc - Major Products and Services
Vertex Pharmaceuticals Inc - History
Vertex Pharmaceuticals Inc - Company Statement
Vertex Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Vertex Pharmaceuticals Inc - Business Description
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Others
Performance
Geographical Segment: United States
Performance
R&D Overview
Vertex Pharmaceuticals Inc - Corporate Strategy
Vertex Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Vertex Pharmaceuticals Inc - Strengths
Vertex Pharmaceuticals Inc - Weaknesses
Vertex Pharmaceuticals Inc - Opportunities
Vertex Pharmaceuticals Inc - Threats
Vertex Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Vertex Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 24, 2021: Vertex to Present at the Cowen Health Care Conference on March
Feb 01, 2021: Vertex Reports Full-Year and Fourth-Quarter 2020 Financial Results
Oct 29, 2020: Vertex reports third-quarter 2020 financial results
Sep 17, 2020: Moderna, Vertex partner on gene-editing therapies for cystic fibrosis
Sep 10, 2020: The Vertex Foundation announces €1 million donation to Ronald McDonald House Charities at the new children’s hospital in Ireland
Jul 30, 2020: Vertex reports second-quarter 2020 financial results
Jun 15, 2020: The Vertex Foundation announces donation to ARCAH to help with COVID-19 response
Jun 15, 2020: The Vertex Foundation announces donation to Tafel Deutschland to help with COVID-19 response
Jun 03, 2020: Vertex appoints Diana McKenzie to its Board of Directors
Apr 29, 2020: Vertex reports first-quarter 2020 financial results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Vertex Pharmaceuticals Inc, Key Facts
Vertex Pharmaceuticals Inc, Key Employees
Vertex Pharmaceuticals Inc, Key Employee Biographies
Vertex Pharmaceuticals Inc, Major Products and Services
Vertex Pharmaceuticals Inc, History
Vertex Pharmaceuticals Inc, Subsidiaries
Vertex Pharmaceuticals Inc, Key Competitors
Vertex Pharmaceuticals Inc, Ratios based on current share price
Vertex Pharmaceuticals Inc, Annual Ratios
Vertex Pharmaceuticals Inc, Annual Ratios (Cont...1)
Vertex Pharmaceuticals Inc, Annual Ratios (Cont...2)
Vertex Pharmaceuticals Inc, Interim Ratios
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Vertex Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Vertex Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Vertex Pharmaceuticals Inc, Ratio Charts
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021